Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044473
Filing Date
2024-11-12
Accepted
2024-11-12 06:27:00
Documents
35
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 362263
2 ex31-1.htm EX-31.1 11938
3 ex31-2.htm EX-31.2 11963
4 ex32-1.htm EX-32.1 6175
5 ex32-2.htm EX-32.2 6009
  Complete submission text file 0001493152-24-044473.txt   1744436

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inti-20240930.xsd EX-101.SCH 11333
7 XBRL CALCULATION FILE inti-20240930_cal.xml EX-101.CAL 19408
8 XBRL DEFINITION FILE inti-20240930_def.xml EX-101.DEF 48550
9 XBRL LABEL FILE inti-20240930_lab.xml EX-101.LAB 121080
10 XBRL PRESENTATION FILE inti-20240930_pre.xml EX-101.PRE 92375
37 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 145252
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13467 | Film No.: 241443021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)